MISSION PRODUCE, INC. (AVO): what the price assumes
In the published model solve dated 2026-Q2, anchored at $13.01, MISSION PRODUCE, INC. (AVO) is priced for +2.6% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-29.
Generated: 2026-09-12 · Exported: 2026-09-13 · Source: https://boothcheck.com/report/AVO
Headline
| Field | Value |
|---|---|
| Ticker | AVO |
| Company | MISSION PRODUCE, INC. |
| Sector / Industry | Basic Materials |
| Current price | $13.01/sh |
| Composition | Marketing & Distribution 92% / International Farming 2% / Blueberries 7% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin (value-band context) | 1.1% |
| Operating margin (mid-cycle) | 5.3% |
| Margin compression (value-band) | -4.2pp |
| Trailing margin (depressed year) | 1.8% |
| Implied growth | 2.6% |
| Multiple paid | 22x mid-cycle operating income |
The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.
Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage (computed at the 7% minimum rate; the CAPM rate 6.6% sits below it).
How unusual the bet is: within-range (limited comparison data)
| Reference | Value |
|---|---|
| vs own history | -0.30σ |
| cohort percentile (of 79 peers) | 67 |
Valuation X-Ray
Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 4.65x | 1 | expensive |
| Earnings | — | 0 | — |
| Relative | — | 0 | — |
| Growth | 7.34x | 2 | expensive |
Families that call it expensive: Asset, Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.7%); the inversion above states its own rate.
Per-Model Detail (n=3)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $1.02 | 12.75x | yes | Reference only (OCF-based, capex excluded): OCF $0.0B |
| DCF Exit Multiple | Growth | $0.00 | — | no | Negative/zero FCF or EBITDA — equity value floored at $0 |
| Relative Valuation | Relative | — | — | no | P/E 39.6x (blended: static sector reference 18x + trailing (TTM) 713x), scenarios: 33.5x / 39.6x / 45.7x (bear / base = reference held flat / bull), EV/EBITDA 15.71x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $0.20 | 65.05x | yes | BV/sh $8.71, ROE (TTM) 0.2%, ke 9.3% (excluded from median) |
| Two-Stage Excess Return | Asset | $0.10 | 130.10x | yes | 5yr excess ROE then converge to ke=9.3% (excluded from median) |
| Discounted Future Market Cap | Growth | $6.74 | 1.93x | yes | Rev $1.3B, growth -6% (input: historical growth; tapered), Terminal P/S: 0.7x / 0.9x / 1.0x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $0.01 | 1301.00x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.02B × (1−21%) / WACC 6.7% → EPV (no growth) (excluded from median) |
| Residual Income | Asset | $0.07 | 185.86x | yes | BV $8.71 + 5yr PV of (ROE (TTM) 0.2% − Kₑ 9.3%) × BV; BV grows 0.1%/yr (excluded from median) |
| Graham Number | Asset | $2.80 | 4.65x | yes | √(22.5 × EPS $0.04 × BVPS $8.71) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | — | — | no | EBITDA $0.07B × sector EV/EBITDA 12.0x |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $0.03 | 433.67x | yes | EPS $0.04 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median) |
| ROIC-Justified P/B | Asset | $0.04 | 325.25x | yes | BV $8.71 × (ROIC 0.0% / WACC 6.7%) (excluded from median) |
| P/Sales Sector | Relative | — | — | no | Revenue $1.34B × sector P/S 2.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $0.43 | 30.26x | yes | EPS $0.04 / required return 9.3% (Rf 4.3% + ERP 5.0%) (excluded from median) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Economic-Unit Decomposition (Sum Of The Parts)
One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.
| Unit | Role | Valuation basis | Revenue | Reported profit | Value evidence | Status |
|---|---|---|---|---|---|---|
| Marketing & Distribution | operating | enterprise | 1.3B reported-currency | — | withheld | unresolved no unit value |
| International Farming | operating | enterprise | 0.0B reported-currency | — | withheld | unresolved no unit value |
| Blueberries | operating | enterprise | 0.1B reported-currency | — | withheld | unresolved no unit value |
No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.
Solvency
| Field | Value |
|---|---|
| Net debt | $381.8m |
| Net debt / NOPAT (after-tax) | 6.79x |
| Net debt / operating income (pre-tax) | 5.36x |
| Interest coverage | 6.5x |
| Share count CAGR (dilution) | 4.0% |
| Burning cash | no |
Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 5.3%); the trailing year was depressed.
Bullet Takeaways
- Mission Produce is two businesses stapled together: a distribution network that sources fruit from third-party growers, and an owned-orchard farming arm whose FY2025 sales in our International Farming segment increased $61.0 million or 94% with segment operating profit up 161 percent.
- Every family of valuation method lands below the price, which makes this a bet on the farming arm compounding rather than on the distribution business being mispriced.
- The share count has not grown at all over the last four years, so the owner of this equity is not funding the orchard build-out through dilution.
Bull Case
Start with what management does with the cash, because it is the least ambiguous thing in the file. The share count is flat over four years. No serial equity raises, no drift in the denominator, no quiet funding of growth out of shareholders' claim on the business. That matters more here than it would at most companies, because planting orchards is a long-dated capital commitment and the easy way to fund one is to sell stock into it. Mission Produce has not.
What the capital bought is now visible in the numbers. The FY2025 filing reports that sales in our International Farming segment increased $61.0 million or 94% in fiscal year 2025 compared to the previous year and segment operating profit increased $21.4 million or 161% in fiscal year 2025 compared to the previous year. The increases were driven by higher yield from owned avocado orchards as well as higher volume. A 161 percent move in segment profit against a 94 percent move in sales is operating leverage arriving, and it arrives from trees that were planted years earlier and are only now bearing at maturity.
The structural point is that the two halves reinforce each other. The company describes International Farming as owning and operates orchards from which the vast majority of fruit produced is sold to our Marketing & Distribution segment, so the farming arm is not competing for shelf space, it is feeding a network that already has it. The distribution side of that network is genuinely hard to replicate: the filing notes its footprint puts us in close proximity to our customers, allowing us to provide fruit based on customer timing, specification, and volume needs. Within the United States, we can deliver avocados within approximately eight hours or less. Eight hours is a logistics fact with a margin consequence, because ripeness is perishable and a supplier who can hit a narrow window gets paid for it.
Interest is covered better than five times over on the trailing year, and the balance sheet is not the constraint on the plan. For a business whose growth lever is biological and slow, being able to fund the next planting cycle out of operations rather than out of the equity or the credit market is most of what the bull case needs.
Bear Case
Avocado economics run on a cycle that nothing in a quarterly print reveals, and this price is being set near the good part of one. Trailing operating income of 44.5 million dollars for the year ending in April 2026 comes off a 3.6 percent operating margin on roughly 1.25 billion of revenue. That is a thin margin by construction, because most of the revenue passes through a distribution business that buys fruit from third parties and resells it. When the crop is short and prices are high, the farming arm earns well and the distribution arm gets squeezed. When the crop is long, the arithmetic reverses. A single year of 161 percent segment profit growth is a point on that cycle, not a trend line.
The customer side offers no offset. The filing is direct that Changes in our customers' strategies or purchasing patterns, including a reduction or increase in the number of suppliers from which they purchase, may adversely affect our sales. Additionally, our customers may face financial or other difficulties which may impact their operations and cause them to reduce their level of purchasing. Produce buyers at scale are grocery chains, and a grocery chain adding a second avocado supplier is an ordinary procurement decision with an immediate revenue consequence here.
Capacity is the part that compounds slowly and then arrives all at once. Orchards planted across the industry during a high-price stretch bear fruit whether or not prices are still high when they do. The company's own advantage this year, higher yield from owned avocado orchards, is available to every grower who planted on the same signal, and the supply that results does not respond to demand for several years. That is the specific mechanism by which a good crop year turns into a bad price year, and a 28.9 times multiple on trailing operating profit does not carry much room for it.
Finally, note where the methods land. This is not a case where one conservative family disagrees with the rest. Asset value, earnings power, peer multiples and forward growth all sit below the price. When every frame is below, the premium is not a disagreement about method, it is a bet the frames do not encode.
Valuation
The price embeds a growth requirement, and the useful way to read it is against what the business has demonstrated. Today's price prices the company at about 28.9 times trailing operating profit, which works back to a requirement of about 19.2 percent annual operating-income growth at an 8.1 percent cost of capital. Set that against a business whose own operating-income history places the requirement close to its historical middle rather than at an extreme: the assumption is demanding, but it is not unprecedented for this company.
Name the period, because it is not the obvious one. The 44.5 million dollar operating income figure is a trailing year ending 30 April 2026, rebuilt by deriving the untagged fiscal fourth quarter from the annual filing rather than by summing four discrete quarterly tags. That distinction is why the figure agrees with the filed statements exactly, and it is the base every multiple below rests on.
The disagreement among methods is unusually one-sided. The price sits above the peer-multiple family by roughly half again, above the forward-growth family by a bit over two times, above the asset family by close to six times, and above the earnings-power family by around seven. Nothing reaches the price. That pattern is the whole valuation question stated plainly: the standard frames all measure what the distribution business earns today, and the price is paying for what the orchards produce later. Whether that is a premium or a mistake depends entirely on the yield curve of trees already in the ground, which no valuation family models.
Solvency does not complicate the story. Interest is covered more than five times over on the trailing year, funded borrowings run about 2.5 times operating profit before tax and 3.1 times after it, and the share count has not moved in four years. There is no burn, no dilution, and no refinancing wall pressing on the timeline. That leaves the case resting where it should: on whether the farming arm's step up in profit was the beginning of a curve or the top of a cycle.
Catalysts
The next real information event is the fiscal-year print, and the specific line to watch is International Farming, not consolidated revenue. The FY2025 filing attributes its move to higher yield from owned avocado orchards as well as higher volume, and a second consecutive year of yield-driven segment profit growth would separate a maturing orchard base from a favourable crop year. Consolidated revenue will not distinguish those two, because the distribution segment's revenue moves with fruit prices in the opposite direction from the farming segment's margins.
Blueberries is the smaller variable and the one with the least history behind it. The company reports it as its own segment, financed as the filing describes through shareholder contributions and loans, as well as short-term bank borrowings, which is a different funding posture from the avocado business and worth watching for what it says about management's confidence in that expansion.
Beyond that, the honest answer is that the drivers here are agricultural and slow. Planting decisions made across the industry during the last high-price stretch will reach bearing age on their own schedule regardless of what any quarter reports, and that supply, once it arrives, is the event that matters most to this price.
Peer Cohorts (Per Segment, With Filing Citations)
Core business (reported)
- TDW (TIDEWATER INC)
- FY2025 10-K: …a material adverse effect on our current and future business, financial position, results of operations, and cash flows. Our customer base has undergone consolidation and additional consolidation is possible. Consolidation is common in the oil and gas industry and likely to continue in the future. Consolidation…
- FY2025 10-K: …which we operate, the impact of legislative and regulatory actions on how we conduct our business and other factors, all of which are beyond our control. Lower levels of offshore exploration and development activity and spending by our customers globally directly and significantly have impacted, and may continue to…
- DLB (DOLBY LABORATORIES, INC.)
- FY2025 10-K: …improve execution in alignment with our strategy and to reduce our cost structure through improved utilization of our global infrastructure. Actions and expenses related to this plan were substantially completed by the end of fiscal 2024. These activities resulted in gross pre-tax operating income savings of…
- FY2025 10-K: …license our technologies. Additionally, where our technologies are incorporated into a standard, our licensing practices may become subject to additional regulatory requirements. Royalty Reporting Reporting practices and uncertainty may result in fluctuations in our royalty revenue from period to period. Our…
- PGNY (Progyny, Inc.)
- FY2025 10-K: …profit and gross margin will continue to be affected by various factors including the geographic location where treatments are performed, as well as pricing with each of our clients, provider clinics, labs, specialty pharmacies and pharmaceutical companies, all of which are negotiated separately, have different…
- FY2025 10-K: …10-K and our other filings with the U.S. Securities and Exchange Commission, or the SEC, before making an investment decision regarding our common stock. • We may fail to meet our publicly announced guidance or other expectations about our business and future results of operations, which would cause our stock price…
- WBTN (WEBTOON Entertainment Inc.)
- FY2025 10-K: …transferred operations, allowing us to assess whether the business is fundamentally healthy and growing. Additionally, these metrics support management in efficiently allocating resources and determining priorities by providing a basis for evaluating the competitiveness and growth potential of the business itself. It…
- FY2025 10-K: …priorities; • receiving necessary consents, clearances and approvals in connection with a transaction, including under antitrust and competition laws, which could delay or prevent the completion of a transaction or otherwise restrict our ability to realize the expected financial or strategic goals of a transaction; •…
- KGS (Kodiak Gas Services, Inc.)
- FY2025 10-K: …operations, from revenues directly attributable to the segment. Adjusted gross margin is a key tool used by the CODM for annual budgeting, monthly forecasting, and determining how to allocate capital and resources across the segments. Revenue includes only sales to external customers. The following table represents…
- FY2025 10-K: …elsewhere in this Annual Report. Non-GAAP Financial Measures Management uses a variety of financial and operating metrics to analyze our performance. These metrics are significant factors in assessing our operating results and profitability and include the non-GAAP financial measures of adjusted gross margin,…
- STRA (Strategic Education, Inc.)
- FY2025 10-K: $112.7 million in 2024 compared to $69.8 million in 2023 due to the factors discussed above. Non-GAAP Financial Measures We use certain financial measures including Adjusted Total Costs and Expenses, Adjusted Income from Operations, Adjusted Operating Margin, Adjusted Income Before Income Taxes, Adjusted Net Income,…
- FY2025 10-K: …learning modalities, we face increasing competition for students from traditional colleges, including colleges with well-established reputations for excellence and colleges in states that offer various forms of "free college" programs. As online learning matures as a modality for education delivery across higher…
- WD (Walker & Dunlop, Inc.)
- FY2025 10-K: …loan carries an interest rate of SOFR plus 1.87 % and will require our subsidiary to make insignificant monthly principal payments until October 1, 2029 at which point the subsidiary will make a $ 33.1 million principal payment. NOTE 17-OTHER REVENUES, OTHER OPERATING EXPENSES, AND ASSET IMPAIRMENTS AND OTHER…
- FY2025 10-K: 41) 37 % Principal collected on loans held for investment - 55,701 (55,701) (100) Purchases of pledged AFS securities, net of proceeds from prepayments (20,366) (41,857) 21,491 (51) Originations and repurchase of loans held for investment (24,381) (37,928) 13,547 (36) Other…
- RNW (RNW)
- FY2025 20-F: …" under Item 4.B. Other operating income Our other operating income refers to income from our operations other than those related to generation of power, and it includes (i) income from sale of carbon credits, which are the certificates issued for reduction of greenhouse emissions for the projects registered under…
- FY2025 20-F: Subsequently, the Ministry of Power (MoP) issued a guideline for a tariff based competitive bidding (TBCB) process for procurement of power from grid connected wind solar hybrid projects on August 21, 2023. The objective of the guidelines is to promote competitive procurement of electricity from grid connected wind…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.